1. Home
  2. Frontier Botanics
  3. The Company
About Us

The Company

A UK-registered company with a wholly owned Lesotho subsidiary, built capital-efficiently to reach operational status.

New Frontier Holdings Ltd (Company No. 12111072), trading as Frontier Botanics, is a UK-registered company with a wholly owned subsidiary in the Kingdom of Lesotho. We were established to build a vertically integrated medicinal cannabis platform from cultivation through processing to European market distribution.

Track record

What We’ve Built

  • A secured cultivation site with perimeter fencing, access control and irrigation infrastructure
  • GACP certification — the EU pharmaceutical standard for agricultural-stage production
  • Proven cultivation operations with genetics optimised for Lesotho’s climate
  • A commercial route-to-market through EU distribution and toll processing partners
  • A lean, experienced management team spanning finance, medicine and law

We achieved operational status for a fraction of the capital consumed by comparable ventures, most of which no longer exist. That capital efficiency is our defining advantage.

People

Leadership

Iain Richardson

CEO & Founder

Entrepreneurial background across multiple sectors. Hands-on operational leadership with deep knowledge of Lesotho and Southern African business. Direct oversight of all cultivation operations.

James Simpson

Finance Director

Financial management and corporate governance. Responsible for capital allocation, investor relations and financial modelling.

Corporate

Company details

Legal entityNew Frontier Holdings Ltd, trading as Frontier Botanics
Company number12111072
UK officeFirst Floor, 690 Great West Road, Osterley Village, Isleworth, England TW7 4PU
Lesotho subsidiaryFrontier Botanics Lesotho (Proprietary) Limited — wholly owned
Morena Khoase Kolobe, Mohalalitoe Road, Maseru, Kingdom of Lesotho
Contact+44 (0) 203 996 1741 · info@frontierbotanics.com
At Frontier Botanics, we are building a trusted, sustainable future for high-quality medical cannabis.
Iain Richardson, CEO & Founder
FAQs

Frequently asked questions

Everything you need to know about Frontier Botanics, our operations, and the investment opportunity. Still have questions? Our team is happy to walk you through the detail.

Get In Touch
Is medical cannabis legal in the UK?

Yes. Medical cannabis has been legal in the UK since November 2018 following changes introduced after high-profile cases like that of Alfie Dingley. However, access is tightly regulated and prescriptions are typically issued by specialist doctors. Frontier Botanics operates fully within UK and international legal frameworks to ensure compliance at every stage of production and distribution.

Why is cultivation based in Lesotho?

Lesotho was the first African nation to legalise medical cannabis cultivation and export, offering a stable regulatory environment, favourable climate, and cost-efficient production conditions. This allows Frontier Botanics to produce high-quality, pharmaceutical-grade cannabis at scale while maintaining competitive pricing for international markets.

What makes Frontier Botanics different from other medical cannabis companies?

Frontier Botanics focuses on vertically integrated operations—from cultivation in Lesotho to distribution in the UK—ensuring full control over quality, compliance, and supply chain efficiency. The company combines pharmaceutical standards with scalable infrastructure, positioning itself to meet growing demand in regulated global markets.

What is the current investment opportunity?

Frontier Botanics is currently raising capital to expand cultivation capacity, enhance processing facilities, and secure additional distribution partnerships. The funding round is designed to accelerate growth, increase production output, and strengthen the company’s position within the rapidly expanding global medical cannabis market.

What is the market potential for medical cannabis?

The global medical cannabis market is projected to grow significantly over the coming decade, driven by increasing legalisation, patient demand, and clinical research. Countries across Europe—including the UK—are gradually expanding access, creating a strong long-term growth opportunity for early-stage, compliant operators like Frontier Botanics.

Invest With Us

Ready to explore the opportunity?

Request the investor information pack or speak directly with the team. Available to eligible High Net Worth and Sophisticated Investors.

CallRequest information